Alexander V Vlassov

Summary

Publications

  1. doi request reprint Exosomes: current knowledge of their composition, biological functions, and diagnostic and therapeutic potentials
    Alexander V Vlassov
    Life Technologies, Austin, TX 78744, USA
    Biochim Biophys Acta 1820:940-8. 2012
  2. doi request reprint Quantification of siRNAs in vitro and in vivo
    Angie Cheng
    Molecular and Cell Biology Division, Life Technologies, Austin, TX, USA
    Methods Mol Biol 764:183-97. 2011
  3. doi request reprint Optimization of transfection conditions and analysis of siRNA potency using real-time PCR
    Angie Cheng
    Molecular and Cell Biology Division, Life Technologies, Austin, TX 78744 1832, USA
    Methods Mol Biol 764:199-213. 2011
  4. pmc The complete exosome workflow solution: from isolation to characterization of RNA cargo
    Jeoffrey Schageman
    Life Technologies, Austin, TX 78744, USA
    Biomed Res Int 2013:253957. 2013
  5. doi request reprint Efficient gene silencing in lungs and liver using imidazole-modified chitosan as a nanocarrier for small interfering RNA
    Bilal Ghosn
    Department of Biomedical Engineering, The University of Texas at Austin, Austin, Texas 78712 0238, USA
    Oligonucleotides 20:163-72. 2010
  6. doi request reprint Stem-loop RT-PCR quantification of siRNAs in vitro and in vivo
    Angie Cheng
    Life Technologies, Austin, TX 78744, USA
    Oligonucleotides 19:203-8. 2009
  7. doi request reprint Locked nucleic acid (LNA)-modified dinucleotide mRNA cap analogue: synthesis, enzymatic incorporation, and utilization
    Anilkumar R Kore
    Life Technologies Corporation, Bioorganic Chemistry Division, 2130 Woodward Street, Austin, Texas 78744 1832, USA
    J Am Chem Soc 131:6364-5. 2009

Collaborators

Detail Information

Publications7

  1. doi request reprint Exosomes: current knowledge of their composition, biological functions, and diagnostic and therapeutic potentials
    Alexander V Vlassov
    Life Technologies, Austin, TX 78744, USA
    Biochim Biophys Acta 1820:940-8. 2012
    ..Exosomes are secreted by all types of cells in culture, and also found in abundance in body fluids including blood, saliva, urine, and breast milk...
  2. doi request reprint Quantification of siRNAs in vitro and in vivo
    Angie Cheng
    Molecular and Cell Biology Division, Life Technologies, Austin, TX, USA
    Methods Mol Biol 764:183-97. 2011
    ..In this chapter, application protocols are described, which enable robust quantification of siRNA, including chemically modified molecules, in vitro and in vivo...
  3. doi request reprint Optimization of transfection conditions and analysis of siRNA potency using real-time PCR
    Angie Cheng
    Molecular and Cell Biology Division, Life Technologies, Austin, TX 78744 1832, USA
    Methods Mol Biol 764:199-213. 2011
    ..In this chapter, we describe a typical in vitro siRNA experiment with optimization of transfection conditions and analysis of siRNA potency, i.e., mRNA knockdown with quantitative real-time PCR...
  4. pmc The complete exosome workflow solution: from isolation to characterization of RNA cargo
    Jeoffrey Schageman
    Life Technologies, Austin, TX 78744, USA
    Biomed Res Int 2013:253957. 2013
    ..Effectiveness of this workflow is exemplified by analysis of the RNA content of exosomes derived from HeLa cell culture media and human serum, using Ion Torrent PGM as a sequencing platform...
  5. doi request reprint Efficient gene silencing in lungs and liver using imidazole-modified chitosan as a nanocarrier for small interfering RNA
    Bilal Ghosn
    Department of Biomedical Engineering, The University of Texas at Austin, Austin, Texas 78712 0238, USA
    Oligonucleotides 20:163-72. 2010
    ..5 mg/kg/day siRNA delivered over 3 consecutive days. In summary, imidazole-modified chitosan-IAA nanoparticles are potentially effective carriers for siRNA delivery...
  6. doi request reprint Stem-loop RT-PCR quantification of siRNAs in vitro and in vivo
    Angie Cheng
    Life Technologies, Austin, TX 78744, USA
    Oligonucleotides 19:203-8. 2009
    ..The application protocols developed enable robust quantification of siRNA, including chemically modified siRNA molecules, in vitro and in vivo...
  7. doi request reprint Locked nucleic acid (LNA)-modified dinucleotide mRNA cap analogue: synthesis, enzymatic incorporation, and utilization
    Anilkumar R Kore
    Life Technologies Corporation, Bioorganic Chemistry Division, 2130 Woodward Street, Austin, Texas 78744 1832, USA
    J Am Chem Soc 131:6364-5. 2009
    ..These findings suggest that the new antireverse cap analogue m(7(LNA))G[5']ppp[5']G 3 is a potential candidate for RNA-based therapeutic vaccine production as well as studying biochemical processes...